(±)-Tetrahydropalmatine
-
(±)-Tetrahydropalmatine
structure -
-
CAS No:
2934-97-6
-
Formula:
C21H25NO4
-
Chemical Name:
(±)-Tetrahydropalmatine
-
Synonyms:
6H-Dibenzo[a,g]quinolizine,5,8,13,13a-tetrahydro-2,3,9,10-tetramethoxy-;Berbine,2,3,9,10-tetramethoxy-,(±)-;6H-Dibenzo[a,g]quinolizine,5,8,13,13a-tetrahydro-2,3,9,10-tetramethoxy-,(±)-;DL-Berbine,2,3,9,10-tetramethoxy-;5,8,13,13a-Tetrahydro-2,3,9,10-tetramethoxy-6H-dibenzo[a,g]quinolizine;dl-Tetrahydropalmatine;(±)-Tetrahydropalmatine;DL-Tetrahydropalmatine;(±)-Corydalis B;(R,S)-Tetrahydropalmatine;Tetrahydropalmatine;THP;2,3,9,10-Tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline;2,3,9,10-Tetramethoxy-5,8,13,13a-tetrahydro-6H-isoquino[3,2-a]isoquinoline;84-38-8;10097-84-4
- Categories:
-
CAS No:
Description
Tetrahydropalmatine, an active component isolated from corydalis, acts through inhibition of amygdaloid release of dopamine to inhibit an epileptic attack in rats.
2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline is an alkaloid.
Drug Information
Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitters. (See all compounds classified as Adrenergic Agents.)|A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS. (See all compounds classified as Analgesics, Non-Narcotic.)|Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)|Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)|Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)|Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)|A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)
(+-)-isomer of tetrahydropalmatine
Computed Properties
Molecular Weight:355.4
XLogP3:3.2
Hydrogen Bond Acceptor Count:5
Rotatable Bond Count:4
Exact Mass:355.17835828
Monoisotopic Mass:355.17835828
Topological Polar Surface Area:40.2
Heavy Atom Count:26
Complexity:475
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Recommended Suppliers of (±)-Tetrahydropalmatine
-
CN
3 YRS
Business licensedTrader Supplier of olive leaf extract,ginger extract,ginseng extract,Black garlic extract,Echinacea purpurea extract,Horse Chestnut Extract,Pueraria extract,Andrographis Extract,citrus aurantium extract,quercetin,Rutin,chlorogenic acid,Curcumin,Apigenin -
CN
2 YRS
Business licensed Certified factoryManufactory Supplier of Ginseng Extract,Hericium Erinaceus Extract,Cranberry Extract,Rosemary Extract,Echinacea Extract,Fruits Powders,API Ingredients,Food Ingredients,Natural Color,Natural antioxidant,Plant Extracts,Milk Thistle Extract,Green Tea Extract,Diosmin,Rutin
Learn More Other Chemicals
-
2,4-Dichloro-3-methylpyridine
132097-09-7
-
2,6-Dibromo-3-fluoropyridine
41404-59-5
-
Triphenylacetic acid
595-91-5
-
3-Chloro-5-fluoro-4-pyridinecarboxylic acid Formula
514798-03-9
-
2-CHLORO-4-PHENYLPYRIDINE Formula
42260-39-9
-
2-Phenyl-4-quinolinecarboxylic acid Formula
132-60-5
-
(-)-Flurbiprofen Structure
51543-40-9
-
Naproxen sodium Structure
26159-34-2
-
What is Glycine, N,N-diethyl-, 4-(acetylamino)phenyl ester, hydrochloride (1:1)
66532-86-3
-
What is 2-[(3-Chlorophenyl)amino]benzoic acid
13278-36-9